ChemoCentryx Inc (CCXI)
NASDAQ
Closed
Aug 24, 2026
Day's Range
13.8152 wk Range
10.07Overview - CCXI - ChemoCentryx Inc
Key Statistics
Valuation
Enterprise Value
810.29M
P/E (Trailing)
‪-7.71‬
P/E (Forward)
‪-69.32‬
PEG Ratio
‪0.06‬
Price / Sales (TTM)
‪25.44‬
Price / Book
‪2.01‬
EV / EBITDA
‪-6.43‬
Profitability
Profit Margin
‪99.05%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-31.67%‬
Return on Equity
‪-32.95%‬
Ownership
Shares Outstanding
55.70M
Float
34.99M
Short % of Shares Outstanding
‪5.06%‬
Held by Insiders
‪6.32%‬
Held by Institutions
‪75.67%‬
Price stats
50-Day Avg
‪14.51‬
200-Day Avg
‪11.80‬
Analyst Consensus
3 analysts
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CCXI - ChemoCentryx Inc
Peers - CCXI - ChemoCentryx Inc
Peer Comparison
Compared with companies in Shell Companies listed on NASDAQ.
Profile Summary - CCXI - ChemoCentryx Inc
About
Churchill Capital Corp XI does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in New York, New York.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
